New York State Common Retirement Fund’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-93
Closed 3532
2022
Q2
$0 Sell
93
-5,070
-98% -$47.8K ﹤0.01% 3578
2022
Q1
$62K Hold
5,163
﹤0.01% 3130
2021
Q4
$101K Sell
5,163
-16
-0.3% -$358 ﹤0.01% 3073
2021
Q3
$135K Sell
5,179
-3,926
-43% -$92.5K ﹤0.01% 3047
2021
Q2
$200K Buy
+9,105
New +$224K ﹤0.01% 3044
2019
Q2
Sell
-1,030
Closed -$40K 3319
2019
Q1
$40K Hold
1,030
﹤0.01% 3093
2018
Q4
$48K Hold
1,030
﹤0.01% 3098
2018
Q3
$141K Hold
1,030
﹤0.01% 2975
2018
Q2
$486K Buy
+1,030
New +$379K ﹤0.01% 2465

Other funds holding NMTR

New York State Common Retirement Fund's NMTR Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 93 shares.

New York State Common Retirement Fund first reported a position in NMTR in Q2 2018 and held it in 9 quarters. The position peaked at $486K in Q2 2018. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 93 9 Meters Biopharma shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 9 quarters.
  • New York State Common Retirement Fund's 9 Meters Biopharma position peaked at $486K in Q2 2018.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.